| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/16/2003 | CN1114591C Cyclic amide compounds |
| 07/16/2003 | CN1114447C Pharmaceutical antiviral compsn. comprising glycyrrhizic acid and at least one protein endowed with activiral activity |
| 07/16/2003 | CN1114442C Burns treating ointment |
| 07/16/2003 | CN1114436C Pharmaceutical and cosmetic formulations with antimicrobial activity |
| 07/16/2003 | CN1114415C Medicine for curing enteritis and bacillary dy sentery |
| 07/16/2003 | CN1114414C Composition and method for treating fungal disease in animals |
| 07/16/2003 | CN1114413C Application of emodin-8-0-beta-D-glucoside |
| 07/16/2003 | CN1114412C Medicine for treating epidemic poultry and animal disease |
| 07/16/2003 | CN1114411C Compound prothiphenyl imidazole emulsion for repelling and curing animal endoparasites and ectoparasites and method for preparing same |
| 07/16/2003 | CN1114410C Product of heat treatment of uronic acid, food, drink and drug containing the product |
| 07/16/2003 | CN1114409C Injection for curing hemoryhoid complicated by anal fistula and its preparation method |
| 07/16/2003 | CN1114407C Use of chelating agent clioquinol for manufacture of pharmaceutical compsn. for treatment of alzheimer's disease |
| 07/16/2003 | CN1114406C Use of (+)-ÔÇÿalphaÔÇÖ-(2,3-dimethyoxyphenyl)-1-[2-(4-fluorophenyl) ethyl]-4-piperidinemethanol in treating mental depression disorders and bipolar psychonosema disorders |
| 07/16/2003 | CN1114405C Gastroprotected omerprazole microgranules, method for obtaining same and pharmaceutical preparation |
| 07/16/2003 | CN1114404C Treatment of diabetes with thiazolidinedione and melbine |
| 07/16/2003 | CN1114403C Vitronectin receptor antagonists |
| 07/16/2003 | CN1114402C Isothiazolones compound, preparation containing them and its use |
| 07/16/2003 | CN1114401C Use of 11-(3-dimethylaminoprpylidene)-6,11-dihydrodibenz [b,e] oxepin-2-acetic acid for manufacture of medicament |
| 07/16/2003 | CN1114399C Ophthalmic composition containing ion sensitive hy drophilic polymer and inorganic salt in ratio which gives low viscosity |
| 07/15/2003 | US6593493 2-(Carboxy(unsaturated)alkyl)-1-(haloalkoxy)benzene derivatives; retinoid X receptors; cardiovascular, skin, eating and vision disorders; anticarcinogenic agents; non-insulin-dependent diabetes |
| 07/15/2003 | US6593482 Methods for preparing new taxoids and pharmaceutical compositions containing them |
| 07/15/2003 | US6593474 Adrenergic blocking agents |
| 07/15/2003 | US6593472 NK-1 receptor active amine oxide prodrugs |
| 07/15/2003 | US6593466 Guanidinium functionalized nucleotides and precursors thereof |
| 07/15/2003 | US6593374 Such as 3-(3'4'5'-trimethoxybenzoyl)-2-(3'benzylphosphate 4'methoxyphenyl)-6-methoxybenzo(b)thiophene; functionalized to prepare phosphate esters, phosphate salts, and phosphoramidates useful as antitumor agents |
| 07/15/2003 | US6593373 Pharmaceutical compositions of O-desmethyl-N-mono-desmethyl-tramadol |
| 07/15/2003 | US6593372 Therapeutic uses for nitric oxide inhibitors |
| 07/15/2003 | US6593371 Treatment for wart and related disorders |
| 07/15/2003 | US6593370 Topical capsaicin preparation |
| 07/15/2003 | US6593369 A prostaglandin applied topically to the clitoris |
| 07/15/2003 | US6593368 Combination with NMDA receptor antagonists, NSAIDs, and analgesics. |
| 07/15/2003 | US6593367 Treatment of addiction and addiction-related behavior |
| 07/15/2003 | US6593366 Ionic polymers as anti-infective agents |
| 07/15/2003 | US6593364 Oxireno-, azetidino-, and methano- picene derivatives |
| 07/15/2003 | US6593363 The present invention relates to diterpene derivatives prepared from the components which are extracted from Acanthopanax Koreanum and represented by Chemical Formula (1). |
| 07/15/2003 | US6593362 Non-peptidic cyclophilin binding compounds and their use |
| 07/15/2003 | US6593361 Method of treating colonic adenomas |
| 07/15/2003 | US6593360 The invention relates to novel 15-membered 8a- and 9a-lactams from the class of 6-O-methyl-erythromycin A of general formula their pharmaceutically acceptable addition salts with inorganic or organic acids and their hydrates, to |
| 07/15/2003 | US6593359 Use of a RAR-γ-specific agonist ligand for increasing the rate of apoptosis |
| 07/15/2003 | US6593357 Treating disease states in mammals that are alleviated by a protein kinase inhibitor, particularly diseases such as cancer, inflammatory disorders, restenosis, and cardiovascular disease. |
| 07/15/2003 | US6593356 The present invention relates to the synthesis of a new class of indeno(1,2-c)pyrazol-4-ones of formula (I): that are potent inhibitors of the class of enzymes known as cyclin dependent kinases, which relate to the catalytic subunits cdk1-7 and the |
| 07/15/2003 | US6593354 Substituted benzoxazole compounds |
| 07/15/2003 | US6593353 p53 inhibitors and therapeutic use of the same |
| 07/15/2003 | US6593352 2-phenylalkylaminobenzoic acid containing substituted benzylsufamoyl group; useful for treating cardiovascular disorders, and for preserving or storing a transplant for surgery |
| 07/15/2003 | US6593351 Carboxylic acid substituted heterocycles, derivatives thereof and methods of use |
| 07/15/2003 | US6593350 For therapy of depression, obsessive compulsive disorder, panic attacks, generalized anxiety disorder, social anxiety disorder, sexual dysfunction, eating disorders, obesity, addictive disorders caused by ethanol or cocaine abuse |
| 07/15/2003 | US6593349 3-(heteroarylamino) indazole, 1,2-benzisothiazole, or 1,2-benzisoxazole derivatives of given formula; for treating nervous system disorders such as pain, anxiety and bipolar disorder |
| 07/15/2003 | US6593347 Nitrosated and nitrosylated nonsteroidal antiinflammatory compounds, compositions and methods of use |
| 07/15/2003 | US6593345 Naphthyl compounds, intermediates, compositions, and methods of use |
| 07/15/2003 | US6593344 These substances have especially high cytostatic activities and pronounced immunosuppressive properties which make them suitable for therapeutic treatment in broad tumor spectrum and autoimmune diseases |
| 07/15/2003 | US6593342 Pharmaceutical compositions comprising 2-quinolones |
| 07/15/2003 | US6593339 Use of compounds as antibacterial agents |
| 07/15/2003 | US6593337 Tricyclic compounds useful as HIV reverse transcriptase inhibitors |
| 07/15/2003 | US6593336 Methods for treating irritable bowel syndrome |
| 07/15/2003 | US6593335 Disease than can be ameliorated with a potassium channel opener in a host mammal, comprising administering to the mammal in need thereof a therapeutically effective amount of the compound of claim 1; said disease is epilepsy, Raynaud's |
| 07/15/2003 | US6593334 Camptothecin-taxoid conjugates as antimitotic and antitumor agents |
| 07/15/2003 | US6593333 Substituted anilino-quinazoline (or quinoline) compounds and use thereof |
| 07/15/2003 | US6593332 Phosphodiesterase inhibitors; sexual disorders |
| 07/15/2003 | US6593331 Method for treatment of pain |
| 07/15/2003 | US6593330 Compounds and their use |
| 07/15/2003 | US6593329 Levosimendan, or (-)-((4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl)hydrazono) -propanedinitrile, which has been previously suggested for the treatment of congestive heart failure is useful in the treatment or prevention of coronary |
| 07/15/2003 | US6593327 Compounds and compositions as protease inhibitors |
| 07/15/2003 | US6593326 Useful as anti-cancer agents; and processes for their manufacture and pharmaceutical compositions containing them are described. Apoptotic effect in a warm-blooded animal such as man. |
| 07/15/2003 | US6593325 Method for the treatment of anxiety which comprises administering to a patient in need of such treatment an effective amount of the compound of claim 1 or a pharmaceutically acceptable salt thereof. |
| 07/15/2003 | US6593324 Dervatives of quinoline as alpha-2 antagonists |
| 07/15/2003 | US6593322 Compounds and methods for modulation of estrogen receptors |
| 07/15/2003 | US6593321 Compounds to inhibit undesired cell proliferation and tumor growth. Additionally, methods are disclosed of treating diseases associated with undesired angiogenesis and undesired proliferation, and methods of treating infectious disease |
| 07/15/2003 | US6593319 Fusidic acid derivatives |
| 07/15/2003 | US6593317 Progestin therapy for maintaining amenorrhea |
| 07/15/2003 | US6593316 And metabolizable precursors incapable of being metabolized to androgens, estrogens or dehydroepiandrosterone |
| 07/15/2003 | US6593313 Co-administration of a prostaglandin and an androgenic agent in the treatment of female sexual dysfunction |
| 07/15/2003 | US6593312 Cyclic α-amino-γ-hydroxyamide compounds |
| 07/15/2003 | US6593311 Sulfated polysaccharide |
| 07/15/2003 | US6593310 Add to a mammal in need of such treatment an effective amount, typically in the range of 0.1 to 100 micrograms per kg of body weight, of a compound capable of maintaining the integrity of connective tissue, for example pentosan polysulfate. |
| 07/15/2003 | US6593307 To antagonize cyclicADPRibose induced calcium release in a cell by contacting the cell with compound of invention |
| 07/15/2003 | US6593306 Methods for modulation and inhibition of telomerase |
| 07/15/2003 | US6593302 Macrolide antiinfective agents |
| 07/15/2003 | US6593301 Ligosaccharide glycosides derived from spirostane with high effective and low side action wherein the dementia is Alzheimer's disease, vascular dementia, or mixed type dementia |
| 07/15/2003 | US6593292 Amidine and/or guanidine substituted peptoid and drug conjugates for drug delivery across endo/epithelial tissue |
| 07/15/2003 | US6593105 Vector comprising a nucleic acid insert; alteration of amino acids within the helix-1 region; inability to convert to a disease-associated form; use in prophylaxis/gene therapy for neurodegenerative diseases |
| 07/15/2003 | US6593078 Use of azetidinone compounds |
| 07/15/2003 | US6592911 (−)-Olivil as antioxidant which is obtained from a new natural source namely Stereospermum personatum |
| 07/15/2003 | US6592910 Methods of treating clinical diseases with isoflavones |
| 07/15/2003 | US6592908 Nutritional or therapeutic compositions |
| 07/15/2003 | US6592904 Atomizing liquid solutions of the macromolecules, drying the droplets, and collecting the particles; process control; especially for proteins, a nucleic acids, and a high molecular weight polysaccharides. |
| 07/15/2003 | US6592903 Redispersibility upon administration to human or animal |
| 07/15/2003 | US6592902 Controlled release eplerenone compositions |
| 07/15/2003 | US6592901 Highly compressible ethylcellulose for tableting |
| 07/15/2003 | US6592894 Hydrogel-isolated cochleate formulations, process of preparation and their use for the delivery of biologically relevant molecules |
| 07/15/2003 | US6592893 Transdermal patch and topical compositions comprising propylnorapomorphine |
| 07/15/2003 | US6592892 Flushable disposable polymeric products |
| 07/15/2003 | US6592891 Plaster for topical use containing heparin and diclofenac |
| 07/15/2003 | US6592885 Forming heat resistant, sustained release antibiotic contain-ing medical garments, gauzes and/or films |
| 07/15/2003 | US6592884 Method of using alpha-keto enamine derivatives as ingredients and products incorporating same |
| 07/15/2003 | US6592879 Sacrificial enzyme substrate system, an enzyme inhibitor system or mixtures or combinations thereof, where the composition reduces skin irritation due to enzyme activity. |
| 07/15/2003 | US6592877 Compounds and methods for immunotherapy and diagnosis of tuberculosis |
| 07/15/2003 | US6592876 Pneumococcal genes, portions thereof, expression products therefrom, and uses of such genes, portions and products |
| 07/15/2003 | US6592862 Methods for the modulation of the growth of collateral arteries and/or other arteries from preexisting arteriolar connections |
| 07/15/2003 | US6592850 Sildenafil citrate chewing gum formulations and methods of using the same |
| 07/15/2003 | US6592848 Ready to use aerosol packages |